A Peculiar Case of Cutaneous Eyelid Melanoma: Clinicopathological Questions and Therapeutic Challenges

1. Boulos PR, Rubin PAD. Cutaneous melanomas of the eyelid. Semin Ophthalmol. 2006 Sep;21(3):195-206.10.1080/08820530500353864Search in Google Scholar

2. Higgins HW, Lee KC, Galan A, Leffell DJ. Melanoma in situ: Part I. Epidemiology, screening, and clinical features. J Am Acad Dermatol. 2015 Aug;73(2):181-90, quiz 191–2.Search in Google Scholar

3. Porras BH, Cockerell CJ. Cutaneous malignant melanoma: classification and clinical diagnosis. Semin Cutan Med Surg. 1997 Jun;16(2):88-96.10.1016/S1085-5629(97)80002-8Search in Google Scholar

4. Beaulieu D, Fathi R, Srivastava D, Nijhawan RI. Current perspectives on Mohs micrographic surgery for melanoma. Clin Cosmet Investig Dermatol. 2018;11:309-20.10.2147/CCID.S137513Search in Google Scholar

5. Silverman N, Shinder R. What’s New in Eyelid Tumors. Asia-Pac J Ophthalmol Phila Pa. 2017 Apr;6(2):143–52.Search in Google Scholar

6. Mattia G, Puglisi R, Ascione B, Malorni W, Carè A, Matarrese P. Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies. Cell Death Dis. 2018 25;9(2):112.10.1038/s41419-017-0059-7Search in Google Scholar

7. Memarzadeh K, Engelsberg K, Sheikh R, Malmsjö M. Large Eyelid Defect Repair Using a Free Full-Thickness Eyelid Graft. Plast Reconstr Surg Glob Open. 2017 Jul 26;5(7).10.1097/GOX.0000000000001413Search in Google Scholar

8. Xu Z, Shi P, Yibulayin F, Feng L, Zhang H, Wushou A. Spindle cell melanoma: Incidence and survival, 1973-2017. Oncol Lett. 2018 Oct;16(4):5091-9.10.3892/ol.2018.9247Search in Google Scholar

9. Cohen PR. Linear Malignant Melanoma In Situ: Reports and Review of Cutaneous Malignancies Presenting as Linear Skin Cancer. Cureus. 2017 Sep;9(9).10.7759/cureus.1696Search in Google Scholar

10. Greenwald HS, Friedman EB, Osman I. Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res. 2012 Feb;22(1):1-8.10.1097/CMR.0b013e32834e6aa0Search in Google Scholar

11. Dummer R, Brase JC, Garrett J, Campbell CD, Gasal E, Squires M, et al. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial. Lancet Oncol. 2020 Jan 30.10.1016/S1470-2045(20)30062-0Search in Google Scholar

12. Rosko AJ, Vankoevering KK, McLean SA, Johnson TM, Moyer JS. Contemporary Management of Early-Stage Melanoma: A Systematic Review. JAMA Facial Plast Surg. 2017 May 1;19(3):232-8.10.1001/jamafacial.2016.184628114438Search in Google Scholar

13. Verga E, Chohan B, Verdolini R. Malignant Melanoma Treated with Topical Imiquimod: A Bespoke Treatment That Spared the Amputation. Case Rep Dermatol. 2019 Apr;11(1):1-6.10.1159/000496052638189530792637Search in Google Scholar

14. Mendoza PR, Grossniklaus HE. Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence? Int Ophthalmol Clin. 2015;55(1):123-36.10.1097/IIO.0000000000000051454826625436498Search in Google Scholar

15. Lazarevic D, Ramelyte E, Dummer R, Imhof L. Radiotherapy in Periocular Cutaneous Malignancies: A Retrospective Study. Dermatol Basel Switz. 2019;235(3):234-9.10.1159/00049653930939473Search in Google Scholar

16. Knackstedt T, Knackstedt RW, Couto R, Gastman B. Malignant Melanoma: Diagnostic and Management Update. Plast Reconstr Surg. 2018;142(2):202e-16e.10.1097/PRS.000000000000457130045186Search in Google Scholar